Factors associated with cognitive evaluations in the United States
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 8, 2014
- Accepted in final form September 15, 2014
- First Published November 26, 2014.
Article Versions
- Previous version (November 26, 2014 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Vikas Kotagal, MD, MS,
- Kenneth M. Langa, MD, PhD,
- Brenda L. Plassman, PhD,
- Gwenith G. Fisher, PhD,
- Bruno J. Giordani, PhD,
- Robert B. Wallace, MD, MS,
- James R. Burke, MD, PhD,
- David C. Steffens, MD, MHS,
- Mohammed Kabeto, MS,
- Roger L. Albin, MD and
- Norman L. Foster, MD
- Vikas Kotagal, MD, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Research support from the American Academy of Neurology Clinical Research Training Fellowship and the Blue Cross Blue Shield of Michigan Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Kenneth M. Langa, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) NIA U01 AG09740, Co-I, 2009-2013; (2) NIA R01 AG030155, Co-I, 2009-2013
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Brenda L. Plassman, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Zinfandel Pharmaceuticals
NIH/NIDCR, R01 DE019110, Investigator, 4/09-4/14
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gwenith G. Fisher, PhD,
NONE
NONE
NONE
Dr. Fisher serves on (1) the editorial board of the Journal of Occupational Health Psychology (2013-present), (2) the editorial board of Work Aging, and Retirement (2013-present), and (3) the editorial board of Journal of Business and Psychology (2014-present).
NONE
NONE
NONE
Dr. Fisher provided consulting services in the form of data analysis, interpretation, and report writing for the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.
NONE
NONE
NONE
NONE
(1) NIOSH/Mountain and Plains Education and Research Center, T42OH009229, Occupational Health Psychology Training Director, 2013-present, (2) NIOSH/CDC, Contract #254‐2010‐M‐37002, Principal Investigator, 2011-2013, (3) NIH/NIA, R37AG007137, Co-PI, 2005-2016, (4) NIH/NIA, U01 AG009740, Research Scientist, 2001-2013, (5) NIH/NIA, R03 AG042919, Co-PI, 2012-2014,
Dr. Fisher was employed as an Associate Research Scientist at the Institute for Social Research, University of Michigan until August, 2013. She is currently Assistant Professor of Psychology at Colorado State University (August, 2013-present) and Faculty Associate at the Institute for Social Research, University of Michigan.
Alfred P. Sloan Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Bruno J. Giordani, PhD,
NONE
NONE
NONE
NONE
NONE
Book published by Springer Press: Neuropsychology of Children in Africa. Published one year ago, with royalties paid of $141.00.
NONE
NONE
NONE
NONE
NONE
NONE
Boivin (PI) 04/01/11 ? 1/31/16 0.78 Cal Mths Michigan State University / NIH-NHLBI $15,822 annual directs/subcontract Computerized Cognitive Rehabilitation in Ugandan Children after Severe Malaria This study investigates the utility of computerized cognitive rehabilitation training in children who have survived cerebral malaria with training aimed at specific cognitive domains our earlier longitudinal studies have identified. Role: Co-I. R01HL105999 Chervin (PI) 12/01/11 ? 11/30/16 0.6 Cal Mths NIH $455,318 annual directs Sleep-Disordered Breathing and CPAP after Adenotonsillectomy in Children This study evaluates the utility of CPAP treatment in children following tonsillectomy with particular reference to cognitive and behavioral features and linkages to newer neurophysiological assessment techniques. Role: Co-I R01 Lozoff (PI) 7/16/12 ? 6/30/17 0.24 Cal Mths NIH $408,874 annual directs Neuromaturational Delays in Iron Deficient Anemic Infants This study will determine long-term neurobiological effects of IDA in infancy, adult functional outcomes related to preventing IDA in infancy, and long-term effects of giving iron to iron-sufficient infants. Role: Co-I R34MH084782 (Boivin) 04/01/2010-03/31/2013 (NCTX 3/31/14) NIH/NIMH Neuropsychological Benefits of Cognitive Training in Ugandan HIV Children. This study will evaluate the neuropsychological benefits of computerized cognitive rehabilitation therapy (CCRT) for Ugandan school children with HIV. Role: Co-I P01NS015655 Frey (PI) 9/15/08 - 6/30/13 (NCTX 6/30/14) NIH/NINDS NCTX 7/31/13PET Study of Biochemistry and Metabolism of the CNS Evaluation of behavioral, sleep, cognitive, and other non- motorized factors associated with Parkinson?s Disease in relation to PET markers out of CNS functioning. Role: Co-I U01HL083219 Ellenberg (PI) 09/25/06 ? 07/31/11 (NCTX 7/31/13) NIH/NHLBI A Randomized Controlled Study of Adenotonsillectomy for Childhood Sleep Apnea A controlled study with sufficient representation of ethnic minorities and comprehensive follow-up to address the role of treatment in pediatric obstructive sleep apnea syndrome, and the potential differential effectiveness among obese children and ethnic minorities. Role: Director of Neuropsychology Assessment and Quality Assurance Core. ADC-030-HBA Weintraub (PI) / Giordani (UM PI) 09/01/07 ? 12/31/12 NIH/NIA (Alzheimer?s Disease Cooperative Study) Multi-Center Trial to Evaluate Home-Based Assessment Methods for Alzheimer?s Disease Prevention Research in People Over 75 Years Old. Role: UM Principal Investigator 2P50 AG008671-16A1 NIH/NIA Gilman (PI) 06/01/05 ? 5/31/11 Michigan Alzheimer's Disease Research Center The major goal of this renewal is the study of the pathophysiologies of early cognitive manifestations of Alzheimer?s disease, emphasizing patients with mild cognitive impairment and very mild Alzheimer?s disease. Role: Associate Director: Center; Director: Clinical Core; Investigator: Projects 2 and 3 5T32HD07422 NICHD/NIH Tate (PI) 05/1/06-4/30/11 The U-M Medical Rehabilitation Research Training Program The purpose of this program is to provide at least two years of research training in medical rehabilitation to post-doctoral fellows in the disciplines of physiatry, psychology, rehabilitation engineering, neurophysiology, biomechanics and other related fields. Role: Director, Neuropsychology Training Core
NONE
Pressler (PI) 7/1/12 ? 6/30/17 0.6 Cal Mths The Rita and Alex Hillman Foundation $591,425 annual directs Effectiveness and Implementation Science for Health Promotion and Chronic Illness Care in Vulnerable Populations This study will prepare the next generation of nurse scholars to lead health care reform. We plan to develop and evaluate a new 3-year PhD program focused on the substantive science areas of health promotion and chronic illness care in vulnerable populations and on intervention research that spans efficacy to effectiveness research and implementation science.
NONE
NONE
NONE
NONE
NONE
NONE
- Robert B. Wallace, MD, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Merck and Co.: Clinical trial safety monitoring Novartis Pharm: Clinical trial safety monitoring
NONE
NONE
NONE
NONE
National Institutes of Health
University of Texas at Austin University of Texas Galveston University of Michigan
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- James R. Burke, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- David C. Steffens, MD, MHS,
NONE
NONE
NONE
International Psychogeriatrics, Editorial Board two years
NONE
(1) The American Psychiatric Press Textbook of Geriatric Psychiatry, APPI, published in 2009
NONE
NONE
NONE
NONE
NONE
NONE
NIMH grants R01 MH054846, R01 MH096725, and K24 MH070027
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Mohammed Kabeto, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Roger L. Albin, MD and
Teva, Serving on DSMB for HD-PRIDE study.
NONE
Travel expenses reimbursed by Parkinson Study Group, Hereditary Disease Foundation.
(1) Neurology - Editorial Board, 9 years; (2) Experimental Neurology - Editorial Board, 15 years; (3) Neurobiology of Disease - Editorial Board, 8 years.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
CHDI Foundation Roger L. Albin, M.D, Principal Investigator P75 Neurotrophin Receptor Signaling in Huntington?s Disease Project Period: 09/01/12 ? 08/31/14 National Institutes of Health R01 NS070856; Nic Bohnen, MD, Principal Investigator Hyposmia, Cholinergic Denervation and Incipient Cognitive Decline in PD Project Period: 09/15/2010 ? 07/31/2015 Role: co-PI National Institutes of Health T32 NS007222; Eva L. Feldman, MD, PhD, Principal Investigator Training in Clinical and Basic Neurosciences Project Period: 07/01/2012 ? 06/30/2017 Role: co-PI Michael J. Fox Foundation for Parkinson?s Research Nic Bohnen, MD, Principal Investigator The Role of Aβ in the Progression of Cognitive Impairment in PD: A Prospective Cohort Study Project Period: 02/01/13 - 01/31/18 Role: co-Investigator Michael J. Fox Foundation for Parkinson?s Research Martijn Muller, PhD, Principal Investigator [18F]flubatine: a Novel Biomarker of Cholinergic α4β2 Nicotinic Receptors and Cognition in Parkinson?s Disease Project Period: 12/01/13 - 12/31/15 Role: co-Investigator National Institutes of Health K08 NS072183; Daniel K. Leventhal, MD, PhD, Principal Investigator Neuronal Oscillations and Dysregulated Motor Learning in Parkinsonian Rats Project Period: 05/01/2013 ? 04/30/2018 Role: co-Investigator National Institutes of Health R21 NS088302 Roger L. Albin, MD, Principal Investigator Cholinergic Interneurons in Tourette Syndrome 6/1/14-5/30/16 National Institutes of Health R25 Roger L. Albin, MD, Principal Investigator University of Michigan Clinical Neuroscientist Training Program (UMCNTP) Project Period: 09/01/14 ? 08/31/19
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Goran, Lucow, Miller; medicolegal consulting; 2013-2014 Johnson & Wyngaarden; medicolegal consulting; 2012-2014
- Norman L. Foster, MD
(1) Bristol-Myers Squibb: Diagnostic Adjudication Committee member (2) PAMS, Inc. Co-Owner and Employee (3) GE Healthcare ad hoc consultant (4) Piramal ad hoc consultant (5) Sanofi Interviewee (6) Lilly USA, LLC Ethics Advisory Board Member
NONE
(1) Human Amyloid Imaging travel reimbursement (2) Alzheimer's Association travel reimbursement (3) American Academy of Neurology honorarium (4) Society or Nuclear Medicine and Molecular Imaging travel reimbursement (5) National Association for Continuing Education (Honorarium and travel reimbursement) (6) Bristol-Myers Squibb travel reimbursement (7) American Federation for Aging Research
NONE
NONE
NONE
NONE
(1) GE Healthcare (2) Piramal
NONE
NONE
NONE
(1) Baxter Bioscience/ADCS, Co-investigator, 2008-13 (2) Janssen Alzheimer Immunotherapy, Co-PI, 2008-13 (3) Eisai / ICON, site co-investigator, 2007-10 (4) GE Healthcare, 18F-39-F-6-OH-BTA1, Co-PI, 2011-14
(1) Northern CA INST Research, AG024904-06, PI, 2012-15 (2) STTR, 1R41AG044147-01, Co-PI, 2012-13 (3) University of Utah, Co-investigator, 2011-12 (4) VA ORH, VISN 19-660, Project Director, 2013-14 (5) ADCS, CERE-110, Co-investigator (6) ADNI, AG024904-06, PI, 2012-15
(1) ADCS/University of California San Diego, ADC030, site co- investigator, 2008-12, (2) University of Pennsylvania, principal investigator, 2005- 09
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Departments of Neurology (V.K., B.J.G., R.L.A.), Internal Medicine (K.M.L., M.K.), Psychiatry (B.J.G.), and Psychology (B.J.G.), University of Michigan, Ann Arbor; Departments of Psychiatry (B.L.P.) and Neurology (J.R.B.), Duke University Medical Center, Durham, NC; Department of Psychology (G.G.F.), Colorado State University, Fort Collins; Department of Epidemiology (R.B.W.), University of Iowa, Iowa City; Department of Psychiatry (D.C.S.), University of Connecticut Health Center, Farmington; and Department of Neurology (N.L.F.), University of Utah, Salt Lake City.
- Correspondence to Dr. Kotagal: vikaskot{at}med.umich.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Dementia and dependenceDo modifiable risk factors delay disability?Pamela M. Rist, Benjamin D. Capistrant, Qiong Wu et al.Neurology, March 28, 2014 -
Articles
Depressive symptoms predict incident stroke independently of memory impairmentsM.M. Glymour, J. Maselko, S.E. Gilman et al.Neurology, December 06, 2010 -
Articles
Cognitive impairment in hemodialysis patients is commonA. M. Murray, D. E. Tupper, D. S. Knopman et al.Neurology, July 24, 2006 -
Articles
Prospective analysis of risk factors for nursing home placement of dementia patientsG. E. Smith, P. C. O’Brien, R. J. Ivnik et al.Neurology, October 23, 2001